The Food and Drug Administration (FDA) intends to award a purchase order to Ani Lytics, 200 Grant Street, Suite 200, Gaithersburg, Maryland 20877. The contractor shall provide 144 each of the following analyses to complete the Developmental Toxicity of Androstenedione in Pregnant Rats: Radioimmunoassay for Androstenedione in blood serum, Radioimmunoassay for Estradiol in blood serum, Radioimmunoassay for FSH in blood serum, Radioimmunoassay for Testosterone in blood serum, Radioimmunoassay for Progesterone in blood serum, Radioimmunoassay for Estriole in blood serum, Radioimmunoassay for LH in blood serum. THIS IS NOT A REQUEST FOR QUOTES; however, sources may submit descriptive literature which fully demonstrates their capabilities which will be considered by the agency to the following address: FDA, 5100 Paint Branch Parkway, HFS-669, Room 4C032, College Park, Maryland 20740-3835. Attn: Patricia Wright or email to: [email protected]. The FDA intends to make an award immediately after the response date of this notice. This sole source procurement is being awarded as a simplified acquisition in accordance with FAR Subpart 13.5.

Bid Protests Not Available